Syndax Pharmaceuticals Inc short interest in 2022
In 2022, Syndax Pharmaceuticals Inc's disclosed short interest ran from 6.80% of shares outstanding on 14 Jan 2022 to 10.58% on 30 Dec 2022, a change of +3.78 percentage points. The year's high was 11.73% on 29 Apr 2022 and its low 6.80% on 14 Jan 2022, averaging 9.11% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.07 days on 29 Apr 2022. Full history: Syndax Pharmaceuticals Inc.
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 6.80% (14 Jan 2022)
- End of year
- 10.58% (30 Dec 2022)
- Change
- +3.78 pp
- High
- 11.73% (29 Apr 2022)
- Low
- 6.80% (14 Jan 2022)
- Average
- 9.11%
- Highest days to cover
- 13.07 (29 Apr 2022)
- SEC filings marked
- 9
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 6.80% | 8.43 | |
| 31 Jan 2022 | 8.52% | 8.12 | |
| 15 Feb 2022 | 9.97% | 9.92 | |
| 28 Feb 2022 | 9.44% | 11.50 | |
| 15 Mar 2022 | 11.21% | 9.40 | 10-K filed, results (8-K) |
| 31 Mar 2022 | 10.14% | 11.17 | |
| 14 Apr 2022 | 11.07% | 8.56 | |
| 29 Apr 2022 | 11.73% | 13.07 | |
| 13 May 2022 | 11.54% | 9.14 | 10-Q filed, results (8-K) |
| 31 May 2022 | 10.80% | 12.95 | |
| 15 Jun 2022 | 10.72% | 9.08 | |
| 30 Jun 2022 | 10.27% | 8.89 | |
| 15 Jul 2022 | 7.72% | 5.83 | |
| 29 Jul 2022 | 7.92% | 7.69 | |
| 15 Aug 2022 | 8.09% | 5.79 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 8.13% | 10.02 | |
| 15 Sep 2022 | 8.13% | 6.64 | |
| 30 Sep 2022 | 7.85% | 6.97 | |
| 14 Oct 2022 | 7.91% | 6.06 | |
| 31 Oct 2022 | 7.19% | 5.72 | |
| 15 Nov 2022 | 6.94% | 4.39 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 7.34% | 8.58 | |
| 15 Dec 2022 | 8.64% | 3.73 | results (8-K) |
| 30 Dec 2022 | 10.58% | 7.54 |
See also: Syndax Pharmaceuticals Inc's full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.